RA Capital Management, LLC, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 525,550 shares at $24.04 ($12.7M) on 2016-09-15, disclosed to the SEC on 2016-09-19.
Open-market sale of $12.7M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 273,000 | $6.6M | 51.5% |
| 2 | $24.04 | 20,000 | $481K | 3.8% |
| 3 | $24.20 | 58,950 | $1.4M | 11.2% |
| 4 | $24.50 | 150,000 | $3.7M | 28.9% |
| 5 | $24.54 | 23,600 | $579K | 4.6% |
| Total | $24.19 avg | 525,550 |
| $12.7M |
| 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |